PDF herunterladen
Semin Respir Crit Care Med 2022; 43(05): 662-674
DOI: 10.1055/s-0042-1742384
Review Article

Obesity and Asthma

Anne E. Dixon
1   Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont
,
Loretta G. Que
2   Department of Medicine, Duke Health, Rm 279 MSRB1, Durham, North Carolina
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Obesity is a major risk factor for the development of asthma, and the prevalence of obesity is higher in people with asthma than in the general population. Obese people often have severe asthma—recent studies in the United States suggest that 60% of adults with severe asthma are obese. Multiple mechanisms link obesity and asthma, which are discussed in this article, and these pathways contribute to different phenotypes of asthma among people with obesity. From a practical aspect, changes in physiology and immune markers affect diagnosis and monitoring of disease activity in people with asthma and obesity. Obesity also affects response to asthma medications and is associated with an increased risk of co-morbidities such as gastroesophageal reflux disease, depression, and obstructive sleep apnea, all of which may affect asthma control. Obese people may be at elevated risk of exacerbations related to increased risk of severe disease in response to viral infections. Interventions that target improved dietary quality, exercise, and weight loss are likely to be particularly helpful for this patient population.

Keywords

airway reactivity - oscillometry - exacerbation - weight loss - diet - co-morbidities - viral infection - gastroesophageal reflux disease - obstructive sleep apnea - depression - type 2 inflammation


Publikationsverlauf

Artikel online veröffentlicht:
17. Februar 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 CDC. Most Recent National Asthma Data. CDC; 2018. . Accessed September 20, 2022 at: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwj89fmYqqP6AhWY2DgGHYrkA0UQFnoECBkQAQ&url=https%3A%2F%2Fdownloads.regulations.gov%2FEPA-HQ-OAR-2018-0283-0724%2Fcontent.pdf&usg=AOvVaw2mB8SSyBfLVBhki04ID39N
    Google Scholar
  • 2 CDC. Asthma: National Health Interview Survey Data. 2021. . Accessed September 20, 2022 at: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjJv93zqqP6AhWVyDgGHTmLD4MQFnoECCYQAQ&url=https%3A%2F%2Fcfpub.epa.gov%2Froe%2Findicator_pdf.cfm%3Fi%3D71&usg=AOvVaw2NnGT-_uEIrcKk5ppleOq7
    Google Scholar
  • 3 Health OoM., Asthma and African Americans.. US Department of Health and Human Services. 2021. . Accessed September 20, 2022 at: https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=15
    Google Scholar
  • 4 Jaacks LM, Vandevijvere S, Pan A. et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol 2019; 7 (03) 231-240
    CrossrefPubMedGoogle Scholar
  • 5 Teague WG, Phillips BR, Fahy JV. et al. Baseline features of the Severe Asthma Research Program (SARP III) cohort: differences with age. J Allergy Clin Immunol Pract 2018; 6 (02) 545-554.e4 , e4
    CrossrefPubMedGoogle Scholar
  • 6 Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175 (07) 661-666
    CrossrefPubMedGoogle Scholar
  • 7 Zhang Y, Chen Z, Berhane K. et al. The dynamic relationship between asthma and obesity in schoolchildren. Am J Epidemiol 2020; 189 (06) 583-591
    CrossrefPubMedGoogle Scholar
  • 8 Contreras ZA, Chen Z, Roumeliotaki T. et al. Does early onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts. Eur Respir J 2018; 52 (03) 52
    CrossrefPubMedGoogle Scholar
  • 9 Lurbet MF, Rojano B, Whittaker Brown SA. et al. Obesity trends among asthma patients in the United States: a population-based study. Ann Glob Health 2019; 85 (01) 85
    PubMedGoogle Scholar
  • 10 Koebnick C, Fischer H, Daley MF. et al. Interacting effects of obesity, race, ethnicity and sex on the incidence and control of adult-onset asthma. Allergy Asthma Clin Immunol 2016; 12: 50
    CrossrefPubMedGoogle Scholar
  • 11 Amin A, Neophytou C, Thein S. et al. L-arginine increases postprandial circulating GLP-1 and PYY levels in humans. Obesity (Silver Spring) 2018; 26 (11) 1721-1726
    CrossrefPubMedGoogle Scholar
  • 12 Lang JE, Bunnell HT, Hossain MJ. et al. Being overweight or obese and the development of asthma. Pediatrics 2018; 142 (06) 142
    Google Scholar
  • 13 Dumas O, Varraso R, Gillman MW, Field AE, Camargo Jr CA. Longitudinal study of maternal body mass index, gestational weight gain, and offspring asthma. Allergy 2016; 71 (09) 1295-1304
    CrossrefPubMedGoogle Scholar
  • 14 Akinbami LJ, Fryar CD. Current asthma prevalence by weight status among adults: United States, 2001-2014. NCHS Data Brief 2016; (239) 1-8
    PubMedGoogle Scholar
  • 15 Kunøe A, Sevelsted A, Chawes BL. et al. Associations between inhaled corticosteroid use in the first 6 years of life and obesity-related traits. Am J Respir Crit Care Med 2021; 204 (06) 642-650
    CrossrefPubMedGoogle Scholar
  • 16 Haldar P, Pavord ID, Shaw DE. et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178 (03) 218-224
    Google Scholar
  • 17 Moore WC, Meyers DA, Wenzel SE. et al; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181 (04) 315-323
    CrossrefPubMedGoogle Scholar
  • 18 Holguin F, Bleecker ER, Busse WW. et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol 2011; 127 (06) 1486-93.e2 , e2
    CrossrefPubMedGoogle Scholar
  • 19 Sideleva O, Dixon AE. The many faces of asthma in obesity. J Cell Biochem 2014; 115 (03) 421-426
    CrossrefPubMedGoogle Scholar
  • 20 Sideleva O, Suratt BT, Black KE. et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med 2012; 186 (07) 598-605
    CrossrefPubMedGoogle Scholar
  • 21 Diaz J, Farzan S. Clinical implications of the obese-asthma phenotypes. Immunol Allergy Clin North Am 2014; 34 (04) 739-751
    CrossrefPubMedGoogle Scholar
  • 22 Forno E, Weiner DJ, Mullen J. et al. Obesity and airway dysanapsis in children with and without asthma. Am J Respir Crit Care Med 2017; 195 (03) 314-323
    CrossrefPubMedGoogle Scholar
  • 23 Zhang RH, Zhou JB, Cai YH. et al. Non-linear association of anthropometric measurements and pulmonary function. Sci Rep 2021; 11 (01) 14596
    CrossrefPubMedGoogle Scholar
  • 24 Bhatawadekar SA, Peters U, Walsh RR. et al. Central airway collapse is related to obesity independent of asthma phenotype. Respirology 2021; 26 (04) 334-341
    CrossrefPubMedGoogle Scholar
  • 25 Skloot G, Permutt S, Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest 1995; 96 (05) 2393-2403
    CrossrefPubMedGoogle Scholar
  • 26 Al-Alwan A, Bates JH, Chapman DG. et al. The nonallergic asthma of obesity. A matter of distal lung compliance. Am J Respir Crit Care Med 2014; 189 (12) 1494-1502
    CrossrefPubMedGoogle Scholar
  • 27 Salome CM, Munoz PA, Berend N, Thorpe CW, Schachter LM, King GG. Effect of obesity on breathlessness and airway responsiveness to methacholine in non-asthmatic subjects. Int J Obes 2008; 32 (03) 502-509
    CrossrefPubMedGoogle Scholar
  • 28 Bates JHT, Peters U, Daphtary N. et al. Altered airway mechanics in the context of obesity and asthma. J Appl Physiol (1985) 2021; 130 (01) 36-47
    CrossrefPubMedGoogle Scholar
  • 29 Bhatawadekar SA, Peters U, Walsh RR. et al. Air trapping versus atelectasis in obesity: relationship to late-onset non-allergic asthma and aging. Ann Am Thorac Soc 2022; 19 (01) 135-139
    CrossrefPubMedGoogle Scholar
  • 30 Kaminsky DA, Chapman DG, Holbrook JT. et al. Older age and obesity are associated with increased airway closure in response to methacholine in patients with asthma. Respirology 2019; 24 (07) 638-645
    CrossrefPubMedGoogle Scholar
  • 31 Peters U, Subramanian M, Chapman DG. et al. BMI but not central obesity predisposes to airway closure during bronchoconstriction. Respirology 2019; 24 (06) 543-550
    CrossrefPubMedGoogle Scholar
  • 32 Duchene B, Caffry S, Kaminsky DA, Que LG, Poynter ME, Dixon AE. Functional significance of 8-isoprostanes in sinonasal disease and asthma. Respir Med 2021; 185: 106506
    CrossrefPubMedGoogle Scholar
  • 33 Holguin F, Grasemann H, Sharma S. et al. L-Citrulline increases nitric oxide and improves control in obese asthmatics. JCI Insight 2019; 4 (24) 4
    CrossrefPubMedGoogle Scholar
  • 34 Lugogo N, Green CL, Agada N. et al. Obesity's effect on asthma extends to diagnostic criteria. J Allergy Clin Immunol 2018; 141 (03) 1096-1104
    CrossrefPubMedGoogle Scholar
  • 35 Desai D, Newby C, Symon FA. et al. Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma. Am J Respir Crit Care Med 2013; 188 (06) 657-663
    CrossrefPubMedGoogle Scholar
  • 36 Farahi N, Loutsios C, Tregay N. et al. In vivo imaging reveals increased eosinophil uptake in the lungs of obese asthmatic patients. J Allergy Clin Immunol 2018; 142 (05) 1659-1662.e8 , e8
    CrossrefPubMedGoogle Scholar
  • 37 Pinkerton JW, Kim RY, Brown AC. et al. Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma. J Allergy Clin Immunol 2021; S0091-6749 (21) 01525-6
    PubMedGoogle Scholar
  • 38 Periyalil HA, Wood LG, Wright TA. et al. Obese asthmatics are characterized by altered adipose tissue macrophage activation. Clin Exp Allergy 2018; 48 (06) 641-649
    CrossrefPubMedGoogle Scholar
  • 39 Peters MC, McGrath KW, Hawkins GA. et al; National Heart, Lung, and Blood Institute Severe Asthma Research Program. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med 2016; 4 (07) 574-584
    CrossrefPubMedGoogle Scholar
  • 40 Toki S, Newcomb DC, Printz RL. et al. Glucagon-like peptide-1 receptor agonist inhibits aeroallergen-induced activation of ILC2 and neutrophilic airway inflammation in obese mice. Allergy 2021; 76 (11) 3433-3445
    CrossrefPubMedGoogle Scholar
  • 41 Foer D, Beeler PE, Cui J, Karlson EW, Bates DW, Cahill KN. Asthma exacerbations in patients with type 2 diabetes and asthma on glucagon-like peptide-1 receptor agonists. Am J Respir Crit Care Med 2021; 203 (07) 831-840
    CrossrefPubMedGoogle Scholar
  • 42 Wu TD, Fawzy A, Akenroye A, Keet C, Hansel NN, McCormack MC. Metformin use and risk of asthma exacerbation among asthma patients with glycemic dysfunction. J Allergy Clin Immunol Pract 2021; 9 (11) 4014-4020.e4
    CrossrefPubMedGoogle Scholar
  • 43 Kuperberg SJ, Navetta-Modrov B. The role of obesity in the immunopathogenesis of COVID-19 respiratory disease and critical illness. Am J Respir Cell Mol Biol 2021; 65 (01) 13-21
    CrossrefPubMedGoogle Scholar
  • 44 Honce R, Schultz-Cherry S. Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol 2019; 10: 1071
    CrossrefPubMedGoogle Scholar
  • 45 Malosh RE, Martin ET, Callear AP. et al. Respiratory syncytial virus hospitalization in middle-aged and older adults. J Clin Virol 2017; 96: 37-43
    CrossrefPubMedGoogle Scholar
  • 46 Martin ET, Archer C, McRoberts J. et al. Epidemiology of severe influenza outcomes among adult patients with obesity in Detroit, Michigan, 2011. Influenza Other Respir Viruses 2013; 7 (06) 1004-1007
    CrossrefPubMedGoogle Scholar
  • 47 Segaloff HE, Evans R, Arshad S. et al. The impact of obesity and timely antiviral administration on severe influenza outcomes among hospitalized adults. J Med Virol 2018; 90 (02) 212-218
    CrossrefPubMedGoogle Scholar
  • 48 To KK, Hung IF, Li IW. et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010; 50 (06) 850-859
    CrossrefPubMedGoogle Scholar
  • 49 Tang M, Henderson RJ, Holbrook JT. et al. Does obesity increase respiratory tract infections in patients with asthma?. J Allergy Clin Immunol Pract 2019; 7 (03) 954-961.e6 , e6
    CrossrefPubMedGoogle Scholar
  • 50 Peters MC, Ringel L, Dyjack N. et al. A transcriptomic method to determine airway immune dysfunction in T2-high and T2-low asthma. Am J Respir Crit Care Med 2019; 199 (04) 465-477
    CrossrefPubMedGoogle Scholar
  • 51 van Huisstede A, Castro Cabezas M, van de Geijn GJ. et al. Underdiagnosis and overdiagnosis of asthma in the morbidly obese. Respir Med 2013; 107 (09) 1356-1364
    CrossrefPubMedGoogle Scholar
  • 52 Aaron SD, Vandemheen KL, FitzGerald JM. et al; Canadian Respiratory Research Network. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA 2017; 317 (03) 269-279
    CrossrefPubMedGoogle Scholar
  • 53 Forno E, Han YY, Mullen J, Celedón JC. Overweight, obesity, and lung function in children and adults-a meta-analysis. J Allergy Clin Immunol Pract 2018; 6 (02) 570-581.e10 , e10
    CrossrefPubMedGoogle Scholar
  • 54 Quinto KB, Zuraw BL, Poon KY, Chen W, Schatz M, Christiansen SC. The association of obesity and asthma severity and control in children. J Allergy Clin Immunol 2011; 128 (05) 964-969
    CrossrefPubMedGoogle Scholar
  • 55 Mosen DM, Schatz M, Magid DJ, Camargo Jr CA. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol 2008; 122 (03) 507-11.e6 , e6
    CrossrefPubMedGoogle Scholar
  • 56 Okubo Y, Nochioka K, Hataya H, Sakakibara H, Terakawa T, Testa M. Burden of obesity on pediatric inpatients with acute asthma exacerbation in the United States. J Allergy Clin Immunol Pract 2016; 4 (06) 1227-1231
    CrossrefPubMedGoogle Scholar
  • 57 Lavoie KL, Bacon SL, Labrecque M, Cartier A, Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006; 100 (04) 648-657
    CrossrefPubMedGoogle Scholar
  • 58 Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006; 27 (03) 495-503
    CrossrefPubMedGoogle Scholar
  • 59 Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007; 101 (11) 2240-2247
    CrossrefPubMedGoogle Scholar
  • 60 Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008; 178 (07) 682-687
    CrossrefPubMedGoogle Scholar
  • 61 Bernstein JA, Virchow JC, Murphy K. et al. Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 2020; 8 (05) 461-474
    CrossrefPubMedGoogle Scholar
  • 62 Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2021. Available from: www.ginasthma.org
    PubMedGoogle Scholar
  • 63 Cloutier MM, Baptist AP, Blake KV. et al; Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC). 2020 Focused Updates to the Asthma Management Guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol 2020; 146 (06) 1217-1270
    CrossrefPubMedGoogle Scholar
  • 64 Corren J, Weinstein S, Janka L, Zangrilli J, Garin M. Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts. Chest 2016; 150 (04) 799-810
    CrossrefPubMedGoogle Scholar
  • 65 Dixon AE, Shade DM, Cohen RI. et al; American Lung Association-Asthma Clinical Research Centers. Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma 2006; 43 (07) 553-558
    CrossrefPubMedGoogle Scholar
  • 66 Yancey SW, Ortega HG, Keene ON. et al. Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma. J Allergy Clin Immunol 2017; 139 (04) 1167-1175.e2 , e2
    CrossrefPubMedGoogle Scholar
  • 67 Castro M, Corren J, Pavord ID. et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 2018; 378 (26) 2486-2496
    Google Scholar
  • 68 Gu C, Upchurch K, Mamaril-Davis J. et al. Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma. Clin Exp Allergy 2020; 50 (10) 1196-1199
    CrossrefPubMedGoogle Scholar
  • 69 Ortega H, Li H, Suruki R, Albers F, Gordon D, Yancey S. Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma. Ann Am Thorac Soc 2014; 11 (07) 1011-1017
    CrossrefPubMedGoogle Scholar
  • 70 Sposato B, Scalese M, Milanese M. et al. Factors reducing omalizumab response in severe asthma. Eur J Intern Med 2018; 52: 78-85
    CrossrefPubMedGoogle Scholar
  • 71 FitzGerald JM, Bleecker ER, Menzies-Gow A. et al. Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies. Lancet Respir Med 2018; 6 (01) 51-64
    Google Scholar
  • 72 Oliveira MJ, Vieira M, Coutinho D. et al. Severe asthma in obese patients: Improvement of lung function after treatment with omalizumab. Pulmonology 2019; 25 (01) 15-20
    CrossrefPubMedGoogle Scholar
  • 73 Crimi C, Campisi R, Cacopardo G. et al. Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities. World Allergy Organ J 2020; 13 (09) 100462
    CrossrefPubMedGoogle Scholar
  • 74 Albers FC, Licskai C, Chanez P. et al. Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma. Respir Med 2019; 159: 105806
    CrossrefPubMedGoogle Scholar
  • 75 Quirce S, Heffler E, Nenasheva N. et al. Revisiting late-onset asthma: clinical characteristics and association with allergy. J Asthma Allergy 2020; 13: 743-752
    CrossrefPubMedGoogle Scholar
  • 76 Kapadia SG, Wei C, Bartlett SJ, Lang J, Wise RA, Dixon AE. American Lung Association Asthma Clinical Research Centers. Obesity and symptoms of depression contribute independently to the poor asthma control of obesity. Respir Med 2014; 108 (08) 1100-1107
    CrossrefPubMedGoogle Scholar
  • 77 Mastronarde JG, Anthonisen NR, Castro M. et al; American Lung Association Asthma Clinical Research Centers. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360 (15) 1487-1499
    Google Scholar
  • 78 Dixon AE, Clerisme-Beaty EM, Sugar EA. et al. Effects of obstructive sleep apnea and gastroesophageal reflux disease on asthma control in obesity. J Asthma 2011; 48 (07) 707-713
    CrossrefPubMedGoogle Scholar
  • 79 Stenius-Aarniala B, Poussa T, Kvarnström J, Grönlund EL, Ylikahri M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000; 320 (7238): 827-832
    CrossrefPubMedGoogle Scholar
  • 80 Johnson JB, Summer W, Cutler RG. et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 2007; 42 (05) 665-674
    CrossrefPubMedGoogle Scholar
  • 81 Scott HA, Gibson PG, Garg ML. et al. Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: a randomized trial. Clin Exp Allergy 2013; 43 (01) 36-49
    CrossrefPubMedGoogle Scholar
  • 82 Jensen ME, Gibson PG, Collins CE, Hilton JM, Wood LG. Diet-induced weight loss in obese children with asthma: a randomized controlled trial. Clin Exp Allergy 2013; 43 (07) 775-784
    CrossrefPubMedGoogle Scholar
  • 83 Dias-Júnior SA, Reis M, de Carvalho-Pinto RM, Stelmach R, Halpern A, Cukier A. Effects of weight loss on asthma control in obese patients with severe asthma. Eur Respir J 2014; 43 (05) 1368-1377
    CrossrefPubMedGoogle Scholar
  • 84 Ma J, Strub P, Xiao L. et al. Behavioral weight loss and physical activity intervention in obese adults with asthma. A randomized trial. Ann Am Thorac Soc 2015; 12 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 85 Freitas PD, Ferreira PG, Silva AG. et al. The role of exercise in a weight-loss program on clinical control in obese adults with asthma. A randomized controlled trial. Am J Respir Crit Care Med 2017; 195 (01) 32-42
    CrossrefPubMedGoogle Scholar
  • 86 Pakhale S, Baron J, Dent R, Vandemheen K, Aaron SD. Effects of weight loss on airway responsiveness in obese adults with asthma: does weight loss lead to reversibility of asthma?. Chest 2015; 147 (06) 1582-1590
    CrossrefPubMedGoogle Scholar
  • 87 Özbey Ü, Balaban S, Sözener ZC, Uçar A, Mungan D, Mısırlıgil Z. The effects of diet-induced weight loss on asthma control and quality of life in obese adults with asthma: a randomized controlled trial. J Asthma 2020; 57 (06) 618-626
    CrossrefPubMedGoogle Scholar
  • 88 Türk Y, Theel W, van Huisstede A. et al. Short-term and long-term effect of a high-intensity pulmonary rehabilitation programme in obese patients with asthma: a randomised controlled trial. Eur Respir J 2020; 56 (01) 56
    CrossrefPubMedGoogle Scholar
  • 89 Dixon AE, Blake KV, DiMango EA. et al. The challenge of addressing obesity in people with poorly controlled asthma. Obes Sci Pract 2021; 7 (06) 682-689
    CrossrefPubMedGoogle Scholar
  • 90 Nyenhuis SM, Shah N, Kim H, Marquez DX, Wilbur J, Sharp LK. The feasibility of a lifestyle physical activity intervention for African American women with asthma. J Allergy Clin Immunol Pract 2021; 9 (12) 4312-4321.e2
    CrossrefPubMedGoogle Scholar
  • 91 Wood LG, Li Q, Scott HA. et al. Saturated fatty acids, obesity, and the nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome in asthmatic patients. J Allergy Clin Immunol 2019; 143 (01) 305-315
    CrossrefPubMedGoogle Scholar
  • 92 Wood LG, Garg ML, Gibson PG. A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma. J Allergy Clin Immunol 2011; 127 (05) 1133-1140
    CrossrefPubMedGoogle Scholar
  • 93 Halnes I, Baines KJ, Berthon BS, MacDonald-Wicks LK, Gibson PG, Wood LG. soluble fibre meal challenge reduces airway inflammation and expression of GPR43 and GPR41 in asthma. Nutrients 2017; 9 (01) 9
    CrossrefPubMedGoogle Scholar
  • 94 Wood LG, Garg ML, Smart JM, Scott HA, Barker D, Gibson PG. Manipulating antioxidant intake in asthma: a randomized controlled trial. Am J Clin Nutr 2012; 96 (03) 534-543
    CrossrefPubMedGoogle Scholar
  • 95 Berthon BS, McLoughlin RF, Jensen ME. et al. The effects of increasing fruit and vegetable intake in children with asthma: a randomized controlled trial. Clin Exp Allergy 2021; 51 (09) 1144-1156
    CrossrefPubMedGoogle Scholar
  • 96 Ma J, Strub P, Lv N. et al. Pilot randomised trial of a healthy eating behavioural intervention in uncontrolled asthma. Eur Respir J 2016; 47 (01) 122-132
    CrossrefPubMedGoogle Scholar
  • 97 Sexton P, Black P, Metcalf P. et al. Influence of Mediterranean diet on asthma symptoms, lung function, and systemic inflammation: a randomized controlled trial. J Asthma 2013; 50 (01) 75-81
    CrossrefPubMedGoogle Scholar
  • 98 Boulet LP, Turcotte H, Martin J, Poirier P. Effect of bariatric surgery on airway response and lung function in obese subjects with asthma. Respir Med 2012; 106 (05) 651-660
    CrossrefPubMedGoogle Scholar
  • 99 Maniscalco M, Zamparelli AS, Vitale DF. et al. Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: a pilot study. Respir Med 2017; 130: 69-74
    CrossrefPubMedGoogle Scholar
  • 100 Guerron AD, Ortega CB, Lee HJ, Davalos G, Ingram J, Portenier D. Asthma medication usage is significantly reduced following bariatric surgery. Surg Endosc 2019; 33 (06) 1967-1975
    CrossrefPubMedGoogle Scholar
  • 101 Dixon AE, Pratley RE, Forgione PM. et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol 2011; 128 (03) 508-15.e1 , 2
    CrossrefPubMedGoogle Scholar
  • 102 Hasegawa K, Tsugawa Y, Chang Y, Camargo Jr CA. Risk of an asthma exacerbation after bariatric surgery in adults. J Allergy Clin Immunol 2015; 136 (02) 288-94.e8 , e8
    CrossrefPubMedGoogle Scholar
  • 103 Forno E, Zhang P, Nouraie M. et al. The impact of bariatric surgery on asthma control differs among obese individuals with reported prior or current asthma, with or without metabolic syndrome. PLoS One 2019; 14 (04) e0214730
    CrossrefPubMedGoogle Scholar
  • 104 van Huisstede A, Rudolphus A, Castro Cabezas M. et al. Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma. Thorax 2015; 70 (07) 659-667
    Google Scholar
  • 105 Sutherland ER, Lehman EB, Teodorescu M, Wechsler ME. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J Allergy Clin Immunol 2009; 123 (06) 1328-34.e1 , e1
    CrossrefPubMedGoogle Scholar
  • 106 Camargo Jr CA, Sutherland ER, Bailey W. et al. Effect of increased body mass index on asthma risk, impairment and response to asthma controller therapy in African Americans. Curr Med Res Opin 2010; 26 (07) 1629-1635
    CrossrefPubMedGoogle Scholar
  • 107 Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celedón JC. Childhood Asthma Management Program Research Group. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol 2011; 127 (03) 741-749
    Google Scholar
  • 108 McGarry ME, Castellanos E, Thakur N. et al. Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma. Chest 2015; 147 (06) 1591-1598
    CrossrefPubMedGoogle Scholar
  • 109 Khurana S, Paggiaro P, Buhl R. et al. Tiotropium reduces airflow obstruction in asthma patients, independent of body mass index. J Allergy Clin Immunol Pract 2019; 7 (07) 2425-2428.e7 , e7
    CrossrefPubMedGoogle Scholar